A61K 9/2059
Starch, including chemically or physically modified derivatives
Official title: {Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin}
A61K9/2059 (Starch, including chemically or physically modified derivatives) appears on 1,434 US grants and 2,835 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,434
- Published applications
- 2,835
- Assignees
- 1,207
- Inventors
- 5,740
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 0 | 0 |
| 1978 | 6 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 5 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 3 | 0 |
| 1991 | 6 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 10 | 0 |
| 1996 | 8 | 0 |
| 1997 | 9 | 0 |
| 1998 | 8 | 0 |
| 1999 | 14 | 0 |
| 2000 | 10 | 0 |
| 2001 | 19 | 12 |
| 2002 | 26 | 44 |
| 2003 | 24 | 60 |
| 2004 | 18 | 78 |
| 2005 | 16 | 88 |
| 2006 | 14 | 60 |
| 2007 | 15 | 89 |
| 2008 | 15 | 77 |
| 2009 | 17 | 83 |
| 2010 | 30 | 104 |
| 2011 | 36 | 97 |
| 2012 | 44 | 118 |
| 2013 | 75 | 130 |
| 2014 | 97 | 126 |
| 2015 | 81 | 136 |
| 2016 | 66 | 117 |
| 2017 | 81 | 143 |
| 2018 | 66 | 129 |
| 2019 | 64 | 134 |
| 2020 | 82 | 164 |
| 2021 | 82 | 159 |
| 2022 | 81 | 158 |
| 2023 | 63 | 148 |
| 2024 | 86 | 142 |
| 2025 | 74 | 127 |
| 2026 | 53 | 112 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse22 Sep 2026US 12,740,948 B2Acura Pharmaceuticals, Inc.
- Pharmaceutical composition of pitolisant hydrochloride and their process for the preparation22 Sep 2026US 12,740,972 B2Msn Laboratories Private Limited, R&D Center
- Soluble pharmaceutical compositions comprising salts of disubstituted 1, 2, 4-triazine compound22 Sep 2026US 12,740,987 B2Mineralys Therapeutics, Inc.
- Chronic kidney disease treatment or prevention method1 Sep 2026US 12,721,844 B2Shionogi & Co., Ltd.
- Method and pharmaceutical composition for treating a sleep disorder8 Oct 2026US 2026/0306442 A1Overseas Pharmaceuticals, Ltd.
- Misoprostol formulation for non-oral administration8 Oct 2026US 2026/0306508 A1Conceptra Biosciences, LLC
- Pharmaceutical composition comprising ibuprofen1 Oct 2026US 2026/0294855 A1
- Trimetazidine solid phases1 Oct 2026US 2026/0294896 A1Les Laboratoires Servier
- Psilocybin compositions, methods of making and methods of using the same1 Oct 2026US 2026/0294939 A1Compass Pathfinder Limited
Most cited
By later US patents
- Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines288US 5,635,517 ACelgene Corporation · 1997
- Methods and compositions for deterring abuse of opioid containing dosage forms267US 7,201,920 B2Acura Pharmaceuticals, Inc. · 2007
- Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations234US 6,046,177 ACydex, Inc. · 2000
- Pharmaceutical compositions of meloxicam with improved solubility and bioavailability166US 6,284,269 B1Hexal AG · 2001
- Isoindolines, method of use, and pharmaceutical compositions163US 6,281,230 B1Celgene Corporation · 2001